Lung cancer: QoL, independence most important to patients

  • Lung Cancer

  • curated by Kelli Whitlock Burton
  • Univadis Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Following treatment for lung cancer, the majority of patients rated QoL and independence as more important than survival and disease recurrence.

Why this matters

  • Nearly half of the patients said they would have preferred a different treatment from the one they received.

Study design

  • 114 patients with stage I lung cancer were surveyed 4-6 months after treatment with stereotactic body radiation therapy (SBRT; 60%) or surgery (40%).
  • Funding: Portland Veterans Affairs Medical Center.

Key results

  • The 4 values ranked as most important were remaining at home (75%), the ability to care for oneself (66%), additional years of life (55%), and risk of recurrence (44%).
  • 83% would accept a 2% chance of periprocedural mortality for 1 additional year of life (89% in SBRT group and 74% in surgery group).
  • 64% would accept a 10% chance of periprocedural mortality for 1 additional year of life and 52% would accept a 20% chance of periprocedural death for 1 additional year of life.
  • Overall, 49% said they would have preferred a different treatment from the one they received.
  • Treatment concordance lower in SBRT group (32%) vs surgery group (81%).

Limitations

  • Patients could not add concerns outside those on the survey.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit